Hadengue, AntoineHôpitaux Universitaires de Genève
Author
Abstract
Alcoholic liver disease is a spectrum of lesions, of which the most severe is alcoholic steatohepatitis (ASH). Recent European guidelines define alcoholic hepatitis as a clinical syndrome: the recent onset of jaundice and/or ascites in a patient with ongoing alcohol misuse. Next to infection, the most frequent aetiology is ASH, a histological diagnosis. In case of severe ASH, as defined by prognostic scores, a biopsy is needed to confirm the diagnosis. Non-severe forms of ASH may improve with interruption of alcohol abuse only; however survival of severe forms of ASH is improved by the association of corticosteroids and N-acetylcysteine. In case of uncontrolled infection, pentoxifylline may be administered. The Lille score, measured at the 7th day of corticosteroid therapy, measures response to therapy and guides the total duration of treatment.
Affiliations
Hôpitaux Universitaires de GenèveService de gastro-entérologie et hépatologie
Citations
APA
Chicago
FWB
Goossens, N., Ditisheim, S., Lanthier, N., Spahr, L., & Hadengue, A. (2012). Alcoholic steatohepatitis: what’s new in 2012? Revue Médicale Suisse, 8(352), 1646-1648. https://hdl.handle.net/2078.5/206082 (Original work published 2012)